Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cell Genesys
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cell Genesys

Cell Genesys

Closed

Cell Genesys Inc., a biotech firm, pioneers in developing cell-based therapies and cancer vaccines in the US.

HQ
Hayward, CA, US
Founded
1988
Overview
Compare
Fundraising
Employees
Website

Cell Genesys Inc., founded with a mission to innovate in the field of biotechnology, focuses on developing advanced cell-based therapies and cancer vaccines. The company's vision is to transform cancer treatment through pioneering biological therapies. Their product portfolio includes cancer vaccines, oncolytic virus therapies, and gene therapies aimed at combating various forms of cancer. Cell Genesys primarily serves the healthcare industry within the United States, striving to improve patient outcomes through cutting-edge scientific research.

Notable figures associated with Cell Genesys include leading scientists and biotech entrepreneurs who have significantly contributed to the field of cancer research. The company has attracted investments from prominent venture capital firms specializing in biotechnology. Key achievements include successful clinical trials and the development of proprietary technologies that have set new standards in cancer treatment. Overall, Cell Genesys has made a substantial impact on the biotech industry by advancing innovative therapies that offer hope to cancer patients.

Cell Genesys - Similar Companies

Geneos Therapeutics logo

Geneos Therapeutics

geneostx.com

Geneius logo

Geneius

geneius.com

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Celltheon logo

Celltheon

celltheon.com

Refuge Biotechnologies logo

Refuge Biotechnologies

Gene Sciences logo

Gene Sciences

Vyant Bio logo

Vyant Bio

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

Cancervax logo

Cancervax

cancervax.com

Cel-Sci logo

Cel-Sci

cel-sci.com

Morphogenesis logo

Morphogenesis

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Cellective BioTherapy logo

Cellective BioTherapy

SynerGene Therapeutics logo

SynerGene Therapeutics

Cell Genesys - Quick Facts

Who are Cell Genesys' competitors?

Companies similar to Cell Genesys include Geneos Therapeutics, Geneius, Cell BioEngines and Celltheon.

When was Cell Genesys founded?

Cell Genesys was founded in 1988.

Where is Cell Genesys' headquarters located?

Cell Genesys' headquarters is located in Hayward, CA, US.

When was Cell Genesys' last funding round?

Cell Genesys' most recent funding round was for $310k (USD) in April 2009.

How much has Cell Genesys raised to-date?

As of Apr 8, 2009, Cell Genesys has raised a total of $310k (USD).

Cell Genesys - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Main Product
  • Cancer Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research